Tourangeau Greg
SEC insider (Form 3/4/5 filer). CIK 0001916566. Principal Accounting Officer at Fulcrum Therapeutics, Inc. (FULC). 3 reported Form 4/5 transactions since Sep 2024; latest on Feb 2, 2026. Located in CAMBRIDGE, MA.
Companies Tourangeau Greg has filed insider reports for
- Fulcrum Therapeutics, Inc. (FULC): Officer, Principal Accounting Officer
Tourangeau Greg
CIK: 0001916566
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)1 (33.3%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (66.7%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
FULC
Fulcrum Therapeutics, Inc.
Officer
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Feb 2, 2026FULC
Fulcrum Therapeutics, Inc.
AwardDirectStock Option (right to buy)
57K shares- - May 8, 2025FULC
Fulcrum Therapeutics, Inc.
SaleDirect498 shares at avg. $5.06$3K - Jan 24, 2025FULC
Fulcrum Therapeutics, Inc.
AwardDirectStock Option (right to buy)
76.1K shares-
1-3 of 3 transactions